Total Voting Rights

RNS Number : 5149P
Futura Medical PLC
04 October 2011
 



For immediate release

4 October 2011

 

 

Futura Medical plc

("Futura" or "the Company")

 

Total Voting Rights

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that, for the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital at the date of this announcement is 73,078,391 ordinary shares of 0.2p each, with one voting right per share. There are no shares held in treasury.

The total number of voting rights in the Company is therefore 73,078,391.

The above figure of 73,078,391 shares may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

 

For any further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

 

Tel: +44 (0)1483 685 670

mail to: james.barder@futuramedical.com

www.futuramedical.com

 

 

 

Nomura Code Securities Limited

 

Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200

 

 

 

For media enquiries please contact:

 

 

 

Buchanan Communications

 

Mark Court / Jessica Fontaine

Tel: +44 (0)20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRMMMGGGDZGMZM
UK 100

Latest directors dealings